I am honored to share this interview with Bernard Siegel, Executive Director of the Regenerative Medicine Foundation (RMF), a global network of stakeholders that fosters collaboration across the industry. Bernard is also the Founder and Chair of the World Stem Cell Summit (WSCS), my favorite stem cell industry event of the year, because it attracts a global super-ecosystem of stem cell industry stakeholders.
Cell and gene therapy companies have been rapidly populating over the past few years, making the cell therapy market a high-value, fast-growth market. Key drivers for the market include high rates of cell therapy clinical trials, accelerated pathways for cell therapy product approvals, new technologies to support cell therapy manufacturing, and the potential for cell therapies to revolutionize healthcare.
The market gained additional momentum when the Swiss pharmaceutical giant Novartis made history as the first company to win FDA approval for a CAR-T cell therapy in the U.S. in August 2017 (Kymriah). In October 2017, Kite Pharma became the second company to get FDA approval of a CAR-T cell therapy (Yescarta).
These historic events demonstrate to investors, the public and funding providers alike that the cell and gene therapy is a market that has emerged, no longer one that is evolving in the future.
With accelerating momentum fueling the industry, BioInformant honored to announce that we are a sponsor for Phacilitate’s Cell and Gene Therapy World in Miami, Florida on January 22-25, 2018. [Read more…]
Recently, I had the honor of interviewing Kyle Cetrulo, CEO of AuxoCell Laboratories. In this interview, we explore the upcoming Future of Regenerative Medicine Congress, as well as future directions for regenerative medicine at large. Enjoy. [Read more…]
Hamburg/Juelich, February 20, 2017 – On April 4, 2017 the first international Stem Cell Community Day will take place in Hamburg. Experts from academia and industry will discuss the status quo, perspectives, and challenges in stem cell cultivation for research and therapy, according to the event’s motto: “Bioprocessing Technologies in Stem Cell Research – Challenges and Chances for Commercialization” [Read more…]
BioInformant is proud to announce its sponsorship of the Future of Regenerative Medicine Congress, May 19-21, 2017 in Teaneck, NJ.
What is the Future of Regenerative Medicine Congress?
“The Future of Regenerative Medicine Congress: Extending and Improving Life with Perinatal, Adipose, and Bone Marrow Cellular Therapy” is a three-day educational conference designed for researchers and medical practitioners that work directly in the field of regenerative medicine. [Read more…]